In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial.
<h4>Background</h4>Loss of mitochondrial function contributes to fatigue, exercise intolerance and muscle weakness, and is a key factor in the disability that develops with age and a wide variety of chronic disorders. Here, we describe the impact of a first-in-class cardiolipin-binding c...
Main Authors: | Baback Roshanravan, Sophia Z Liu, Amir S Ali, Eric G Shankland, Chessa Goss, John K Amory, H Thomas Robertson, David J Marcinek, Kevin E Conley |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0253849 |
Similar Items
-
A randomized crossover trial of elamipretide in adults with primary mitochondrial myopathy
by: Amel Karaa, et al.
Published: (2020-08-01) -
Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
by: Weixing Zhao, et al.
Published: (2019-11-01) -
Building strength, endurance, and mobility using an astaxanthin formulation with functional training in elderly
by: Sophia Z. Liu, et al.
Published: (2018-10-01) -
The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis
by: Joshua A. Grosser, et al.
Published: (2021-05-01) -
Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice
by: Youmei Zuo, et al.
Published: (2020-08-01)